Results 201 to 210 of about 51,073 (294)

Polypharmacy increases the risk of Parkinson's disease in older people in Taiwan: A population‐based study [PDF]

, 2011
Shih-Wei Lai, Li‐Ting Su, Chih‐Hsueh LIN, Chon‐Haw TSAI, Fung‐Chang Sung, Dennis P. H. Hsieh   +5 more
openalex   +1 more source

Geriatric polypharmacy in Taiwan

Journal of the Formosan Medical Association, 2016
Tai-Yin Wu, Chien-Chih Chen, Ying-Hui Wu
openaire   +4 more sources

Beyond BMI: Practical Guide for Clinicians to Integrate the Lancet Commission's Obesity Framework and King's Obesity Staging System

Clinical Obesity, EarlyView.
ABSTRACT Body mass index (BMI) on its own is a poor diagnostic and staging tool for obesity because it does not measure health status. The newly published Lancet Clinical Obesity Criteria (LCOC) for defining clinical obesity distinguish preclinical and clinical obesity based on organ or tissue dysfunction.
Tak Ying Louise Ko, Alexander D. Miras, Dimitri J. Pournaras, Carel W. Le Roux   +3 more
wiley   +1 more source

Reframing Polypharmacy: Empowering Medical Students to Manage Medication Burden as a Chronic Condition. [PDF]

Clin Pract
Conte A, Sedghi A, Majeed A, Jerjes W.
europepmc   +1 more source

Polypharmacy: should we or shouldn't we? [PDF]

, 2011
Rajesh K. Rajpal, Elizabeth B. Owens, MacDara McCauley   +2 more
openalex   +1 more source

Geriatric Vulnerability Instruments Predict Critical Outcomes Potentially Missed by Standard Emergency Department Severity Triage

Academic Emergency Medicine, EarlyView.
Magali Aldrin Lopes Marion, Pedro Kallas Curiati, Renata Lourenzen de Oliveira, Christian Valle Morinaga   +3 more
wiley   +1 more source

Clinical risk phenotypes in diabetes and their associations with adverse cardiovascular events: A report from the Silesia Diabetes‐Heart Project

Diabetic Medicine, EarlyView.
Abstract Aims Diabetes is characterized by clinical heterogeneity. This study aimed to identify different clinical phenotypes of real‐world people with diabetes and to assess their associations with major adverse cardiovascular events (MACEs). Methods From a prospective Polish registry of people with diabetes, hierarchical cluster analysis was ...
Marta Mantovani, Hanna Kwiendacz, Krzysztof Irlik, Tommaso Bucci, Mirela Hendel, Steven H. M. Lam, Bi Huang, Paulina Szromek‐Białek, Monika Niezgoda, Uazman Alam, Giuseppe Boriani, Janusz Gumprecht, Gregory Y. H. Lip, Katarzyna Nabrdalik   +13 more
wiley   +1 more source

Prevalence and Determinants of Frailty in Community-Dwelling Iranian Older Adults: A Cross-Sectional Study. [PDF]

Health Sci Rep
Rahimi M, Shirdozham M, Feizi A.
europepmc   +1 more source

PMH79 PSYCHOTROPIC POLYPHARMACY IN CHILDREN AND ADOLESCENTS WITH ATTENTION – DEFICIT / HYPERACTIVITY DISORDER [PDF]

, 2011
Swetha Palli, Rajender R. Aparasu, H. Chen, Jeffrey T. Sherer   +3 more
openalex   +1 more source

Partial non‐adherence to antidiabetic therapy undermines diabetes management and correlates with treatment complexity: A cross‐sectional study using blood plasma analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate medication adherence in patients with type 2 diabetes (T2D) using plasma drug measurements and assess the clinical impact of partial non‐adherence on glycemic control and complications. Materials and Methods This cross‐sectional study included 641 T2D outpatients attending routine follow‐up visits.
Vojtěch Škop, Ivana Laňková, Simona Antalová, Iva Míšková, Kateřina Malá‐Ládová, Josef Malý, Terezie Pelikánová, Jiří Hricko, Tomáš Čajka, Martin Haluzík   +9 more
wiley   +1 more source